Literature DB >> 18250997

Uridine adenosine tetraphosphate acts as an autocrine hormone affecting glomerular filtration rate.

V Jankowski1, A Patzak, S Herget-Rosenthal, Thi Nguyet Anh Tran, En Yin Lai, T Günthner, I Buschmann, W Zidek, J Jankowski.   

Abstract

Recently, uridine adenosine tetraphosphate (Up(4)A) was described as a strong vasoconstrictor released from endothelial cells after stimulation with mechanical stress. In this study, we isolated and identified Up(4)A from kidney tissue, and we characterized the essential varying effects of Up(4)A on the afferent and efferent arterioles. Porcine and human kidney tissue was fractionated by size exclusion chromatography, affinity chromatography, anion exchange chromatography and reverse phase chromatography. In fractions purified to homogeneity, Up(4)A was identified by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF MS), MALDI-LIFT fragment mass spectrometry (MALDI-TOF/TOF MS), retention-time comparison and enzymatic cleavage analysis. We analysed the release of Up(4)A from cultivated renal proximal tubule cells after stimulation of protein kinase C with oleoyl-2-acetyl-sn-glycerol (OAG). Up(4)A was identified in renal tissue, and the effect of Up(4)A on the vascular tone of isolated perfused afferent and efferent arterioles was tested. Stimulation of tubule cells with OAG increased the release rate of Up(4)A from tubule cells about tenfold. Up(4)A acts as a strong vasoconstrictive mediator on afferent arterioles, but has no significant effect on the tone of efferent arterioles, suggesting a functional role of Up(4)A as an autocrine hormone for glomerular perfusion. Because of the predominant effect of the Up(4)A on afferent arterioles, we assume that Up(4)A may decrease glomerular perfusion, intra-glomerular pressure and, hence, glomerular filtration rate. The release of Up(4)A from renal tubular cells may be an additional mechanism whereby tubular cells could affect renal perfusion. Up(4)A release may further contribute to renal vascular autoregulation mechanisms. In conclusion, as Up(4)A occurs in renal tissue and has marked effects on afferent but not efferent arterioles, Up(4)A may play a role in renal hemodynamics and possibly blood pressure regulation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18250997     DOI: 10.1007/s00109-008-0306-6

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  22 in total

1.  Mass-spectrometry-linked screening of protein fractions for enzymatic activities--a tool for functional genomics.

Authors:  J Jankowski; N Stephan; M Knobloch; S Fischer; D Schmaltz; W Zidek; H Schlüter
Journal:  Anal Biochem       Date:  2001-03       Impact factor: 3.365

Review 2.  Purinergic signaling and vascular cell proliferation and death.

Authors:  Geoffrey Burnstock
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-03-01       Impact factor: 8.311

3.  Purification of chemically synthesised dinucleoside(5',5') polyphosphates by displacement chromatography.

Authors:  J Jankowski; W Potthoff; W Zidek; H Schlüter
Journal:  J Chromatogr B Biomed Sci Appl       Date:  1998-11-20

4.  The action of a water-soluble carbodiimide on adenosine-5'-polyphosphates.

Authors:  K E Ng; L E Orgel
Journal:  Nucleic Acids Res       Date:  1987-04-24       Impact factor: 16.971

5.  Diinosine pentaphosphate (IP5I) is a potent antagonist at recombinant rat P2X1 receptors.

Authors:  B F King; M Liu; J Pintor; J Gualix; M T Miras-Portugal; G Burnstock
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

6.  Alpha-cyano-4-hydroxycinnamic acid affinity sample preparation. A protocol for MALDI-MS peptide analysis in proteomics.

Authors:  J Gobom; M Schuerenberg; M Mueller; D Theiss; H Lehrach; E Nordhoff
Journal:  Anal Chem       Date:  2001-02-01       Impact factor: 6.986

7.  Physiological role for P2X1 receptors in renal microvascular autoregulatory behavior.

Authors:  Edward W Inscho; Anthony K Cook; John D Imig; Catherine Vial; Richard J Evans
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

8.  Increased uridine adenosine tetraphosphate concentrations in plasma of juvenile hypertensives.

Authors:  Vera Jankowski; Andreas-Alexander Meyer; Peter Schlattmann; Yu Gui; Xi-long Zheng; Irini Stamcou; Kristina Radtke; Thi Nguyet Anh Tran; Markus van der Giet; Markus Tölle; Walter Zidek; Joachim Jankowski
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-06-14       Impact factor: 8.311

9.  Effects of ATP on pre- and postglomerular juxtamedullary microvasculature.

Authors:  E W Inscho; K Ohishi; L G Navar
Journal:  Am J Physiol       Date:  1992-11

10.  Inotropic effects of diadenosine tetraphosphate (AP4A) in human and animal cardiac preparations.

Authors:  U Vahlensieck; P Bokník; I Gombosová; S Huke; J Knapp; B Linck; H Lüss; F U Müller; J Neumann; M C Deng; H H Scheld; H Jankowski; H Schlüter; W Zidek; N Zimmermann; W Schmitz
Journal:  J Pharmacol Exp Ther       Date:  1999-02       Impact factor: 4.030

View more
  14 in total

1.  Alterations in vasoconstrictor responses to the endothelium-derived contracting factor uridine adenosine tetraphosphate are region specific in DOCA-salt hypertensive rats.

Authors:  Takayuki Matsumoto; Rita C Tostes; R Clinton Webb
Journal:  Pharmacol Res       Date:  2011-09-14       Impact factor: 7.658

Review 2.  Purinergic signalling in the kidney in health and disease.

Authors:  Geoffrey Burnstock; Louise C Evans; Matthew A Bailey
Journal:  Purinergic Signal       Date:  2013-11-22       Impact factor: 3.765

Review 3.  Dinucleoside polyphosphates: strong endogenous agonists of the purinergic system.

Authors:  Vera Jankowski; Markus van der Giet; Harald Mischak; Michael Morgan; Walter Zidek; Joachim Jankowski
Journal:  Br J Pharmacol       Date:  2009-06-25       Impact factor: 8.739

4.  Uridine adenosine tetraphosphate is a novel neurogenic P2Y1 receptor activator in the gut.

Authors:  Leonie Durnin; Sung Jin Hwang; Masaaki Kurahashi; Bernard T Drumm; Sean M Ward; Kent C Sasse; Kenton M Sanders; Violeta N Mutafova-Yambolieva
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-23       Impact factor: 11.205

Review 5.  Uridine adenosine tetraphosphate and purinergic signaling in cardiovascular system: An update.

Authors:  Zhichao Zhou; Takayuki Matsumoto; Vera Jankowski; John Pernow; S Jamal Mustafa; Dirk J Duncker; Daphne Merkus
Journal:  Pharmacol Res       Date:  2018-12-13       Impact factor: 7.658

6.  Mechanisms underlying uridine adenosine tetraphosphate-induced vascular contraction in mouse aorta: Role of thromboxane and purinergic receptors.

Authors:  Zhichao Zhou; Changyan Sun; Stephen L Tilley; S Jamal Mustafa
Journal:  Vascul Pharmacol       Date:  2015-04-25       Impact factor: 5.773

7.  P2X(1) receptor blockade inhibits whole kidney autoregulation of renal blood flow in vivo.

Authors:  David A Osmond; Edward W Inscho
Journal:  Am J Physiol Renal Physiol       Date:  2010-03-24

8.  Uridine adenosine tetraphosphate-induced contraction is increased in renal but not pulmonary arteries from DOCA-salt hypertensive rats.

Authors:  Takayuki Matsumoto; Rita C Tostes; R Clinton Webb
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-05-06       Impact factor: 4.733

9.  Impaired Aortic Contractility to Uridine Adenosine Tetraphosphate in Angiotensin II-Induced Hypertensive Mice: Receptor Desensitization?

Authors:  Zhichao Zhou; Vishal R Yadav; Changyan Sun; Bunyen Teng; Jamal S Mustafa
Journal:  Am J Hypertens       Date:  2017-03-01       Impact factor: 2.689

10.  The role of uridine adenosine tetraphosphate in the vascular system.

Authors:  Takayuki Matsumoto; Rita C Tostes; R Clinton Webb
Journal:  Adv Pharmacol Sci       Date:  2011-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.